Subscribe to Newsletter

Vaccines

Manufacture Vaccines

The Road Ahead for mRNA Manufacturers

| Sponsored by Thermo Fisher Scientific | 8 min read

Though key hurdles remain, there is huge potential for mRNA-based therapeutics to tackle areas of unmet need.

Discovery & Development Formulation

Goodbye, Moisture. Hello, mRNA

| Stephanie Vine | 2 min read

Could dry vaccines help improve global access to the latest vaccine technologies?

Manufacture Vaccines

The Next Wave of RNA Therapeutics

| Pirkko Muhonen, Sirat Sikka | 6 min read

Exploring the potential of self-amplifying RNA and circular RNA in the future of drug development.

Manufacture Vaccines

“Could You Patent the Sun?” – Jonas Salk, Albert Sabin, and the Polio Vaccine

| Angus Stewart | 18 min read

How two rival projects relate to a modern disease landscape threatened by climate change and low vaccination rates

Manufacture Bioprocessing - Upstream & Downstream

Mastering mRNA Manufacturing

| Sponsored by Sartorius | 7 min read

Experts from Sartorius give advice on the next generation processes and facilities for mRNA manufacture.

Manufacture Vaccines

Lessons Learned: Leveraging Pandemic Pandemonium for a Better Future

| Bryan Ennis | 7 min read

How can our knowledge of mRNA vaccine development influence our Industry 4.0 journeys?

Manufacture Contract Manufacturing Services

Adversity, Adaption, Delivery, Expansion

| Sponsored by PCI | 8 min read

How one CDMO navigated the pandemic and came out on top of industry trends

Business & Regulation COVID-19

Enter the Weird World of Anti-Vaxxers

| Stephanie Vine | 3 min read

Why, oh why, is there so much nonsense and misinformation about COVID-19 vaccines?

Manufacture Vaccines

mRNA IVT: A Modern Balancing Act

| Jeneffer England | 6 min read

Optimizing mRNA in vitro transcription processes is important – and high-quality kits are a great starting point.

Manufacture Bioprocessing - Upstream & Downstream

Delving into the Trends of the Biopharma Industry

| Stephanie Vine

The Medicine Maker and NIBRT present the Biopharma Trends Leaders’ Report 2022.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register